id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S4961 R13017 |
De Lorenzo (Controls unexposed, disease free), 2020 | Malformations | at least 1st trimester | retrospective cohort | unexposed, disease free excluded | Adjustment: No |
17.50 [1.28;238.92] C excluded (control group) |
2/6 1/36 | 3 | 6 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4960 R13011 |
De Lorenzo (Controls unexposed, sick), 2020 | Malformations | at least 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 45.00 [1.78;1138.73] C | 2/6 0/32 | 2 | 6 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4994 R13078 |
Drechsel, 2020 | Major congenital malformations | 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 2.53 [0.10;67.19] C | 0/9 1/66 | 1 | 9 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4996 R13097 |
Fu, 2019 | Congenital malformation (major or minor) | 1st trimester | randomized controlled trial | unexposed, sick | Adjustment: Randomisation | 1.59 [0.14;17.92] C | 2/85 1/67 | 3 | 85 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3011 R11374 |
Carman (Control unexposed, disease free), 2017 | Major malformations | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, disease free excluded | Adjustment: No |
0.95 [0.49;1.85] C excluded (control group) |
11/210 59/1,078 | 70 | 210 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3010 R11375 |
Carman (Control unexposed, sick), 2017 | Major malformations | during pregnancy (anytime or not specified) excluded | retrospective cohort (claims database) | unexposed, sick | Adjustment: No |
1.08 [0.57;2.05] C excluded (exposition period) |
11/210 94/1,932 | 105 | 210 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3004 R11377 |
Hoxha, 2017 | Congenital malformation | 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 0.19 [0.01;5.20] C | 0/17 1/11 | 1 | 17 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4081 R11372 |
Bröms (controls unexposed, disease free), 2016 | Any major birth defect | 3 months or more before pregnancy or1st trimester | population based cohort retrospective | unexposed, disease free excluded | Adjustment: No |
1.71 [1.13;2.59] C excluded (control group) |
24/344 52,592/1,250,192 | 52,616 | 344 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3195 R11373 |
Bröms (controls unexposed, sick), 2016 | Any major birth defect | 3 months or more before pregnancy or1st trimester excluded | population based cohort retrospective | unexposed, sick | Adjustment: Yes |
1.49 [0.92;2.28] excluded (exposition period) |
24/344 1,019/21,549 | 1,043 | 344 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3137 R11376 |
Chambers, 2015 | Major birth defects in live born infants | at least 1st trimester | prospective cohort | unexposed, sick | Adjustment: Yes | 2.77 [1.04;7.35] | -/- -/- | - | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2913 R11379 |
Weber-Schoendorfer, 2015 | Major birth defects | 1st trimester | prospective cohort | unexposed, disease free | Adjustment: No | 3.71 [1.47;9.40] C | 6/111 21/1,385 | 27 | 111 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S13722 R53454 |
Viktil (Controls exposed to other treatments), 2012 | Major malformations | 3 months or more before pregnancy or1st trimester | population based cohort propective | exposed to other treatment, sick excluded | Adjustment: No |
0.37 [0.02;6.16] C excluded (control group) |
0/37 50/1,424 | 50 | 37 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S13723 R53456 |
Viktil (Controls unexposed, NOS), 2012 | Major malformations | 3 months or more before pregnancy or1st trimester excluded | population based cohort propective | unexposed (general population or NOS) | Adjustment: No |
0.41 [0.03;6.70] C excluded (exposition period) |
0/37 5,000/154,976 | 5,000 | 37 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4998 R15978 |
Hyrich, 2006 | Major fetal abnormalities | 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 0.79 [0.01;44.65] C | 0/10 0/8 | 0 | 10 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 7 studies | 2.93 [1.53;5.60] | 34 | 238 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, sick;
Asymetry test p-value = 0.5981 (by Egger's regression)
slope=1.3822 (0.6260); intercept=-0.4300 (0.7645); t=0.5625; p=0.5981
excluded 13722, 4081, 3011, 4961